[go: up one dir, main page]

KR870008028A - 생물학적으로 활성인단백질의 제조방법 - Google Patents

생물학적으로 활성인단백질의 제조방법 Download PDF

Info

Publication number
KR870008028A
KR870008028A KR1019860001221A KR860001221A KR870008028A KR 870008028 A KR870008028 A KR 870008028A KR 1019860001221 A KR1019860001221 A KR 1019860001221A KR 860001221 A KR860001221 A KR 860001221A KR 870008028 A KR870008028 A KR 870008028A
Authority
KR
South Korea
Prior art keywords
bgh
composition
cows
valine
milk secretion
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
KR1019860001221A
Other languages
English (en)
Other versions
KR920000849B1 (ko
Inventor
지. 크리비 그웬
Original Assignee
몬산토 캄파니
아놀드 하베이 콜
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US06/704,362 external-priority patent/US4861868A/en
Application filed by 몬산토 캄파니, 아놀드 하베이 콜 filed Critical 몬산토 캄파니
Publication of KR870008028A publication Critical patent/KR870008028A/ko
Application granted granted Critical
Publication of KR920000849B1 publication Critical patent/KR920000849B1/ko
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/61—Growth hormone [GH], i.e. somatotropin
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K20/00—Accessory food factors for animal feeding-stuffs
    • A23K20/10—Organic substances
    • A23K20/168—Steroids
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K20/00—Accessory food factors for animal feeding-stuffs
    • A23K20/10—Organic substances
    • A23K20/184—Hormones
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K50/00—Feeding-stuffs specially adapted for particular animals
    • A23K50/10—Feeding-stuffs specially adapted for particular animals for ruminants
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K50/00—Feeding-stuffs specially adapted for particular animals
    • A23K50/30—Feeding-stuffs specially adapted for particular animals for swines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/27—Growth hormone [GH], i.e. somatotropin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Zoology (AREA)
  • Engineering & Computer Science (AREA)
  • Polymers & Plastics (AREA)
  • Endocrinology (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Husbandry (AREA)
  • Medicinal Chemistry (AREA)
  • Food Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • Wood Science & Technology (AREA)
  • Toxicology (AREA)
  • Birds (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Plant Pathology (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Microbiology (AREA)
  • Physics & Mathematics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

내용 없음

Description

생물학적으로 활성인단백질의 제조방법
본 내용은 요부공개 건이므로 전문내용을 수록하지 않았음

Claims (29)

  1. 조성물내의 전체 bGH 중량에 대하여 제126위에 또는 그 주위에 발린을 갖는 bGH의 농도가 혼주된 뇌하수체 bGH중 동일한 위치에 발린을 갖는 bGH 농도보다 실제로 크게하여 제126위에 또는 그 주위에 발린을 갖는 bGH를 적어도 하나 포함하는 조성물.
  2. 제 1 항에 있어서, 본질적으로 모든 bGH는 발린을 포함함을 특징으로 하는 조성물.
  3. 제 1 항에 있어서, 젖소에 투여 적합한 것을 특징으로 하는 조성물.
  4. 제 1 항에 있어서, 젖소에 투여한 경우에 혼주된 뇌하수체 bGH 동몰량을 투어한 것보다 젖소의 유즙분비를 더욱 향상시키는 것을 특징으로 하는 조성물.
  5. 제 1 항에 있어서, 젖소에 투여한 경우에 bGH(A,L)동몰량을 여한 것보다 젖소의 유즙분비를 더욱 향상시키는 것을 특징으로 하는 조성물.
  6. 본질적으로 순수한 발린 bGH를 포함함을 특징으로 하는 조성물.
  7. 제 6 항에 있어서, 발린 bGH는 bGH(A,V)를 포함함을 특징으로 하는 조성물.
  8. 발린을 포함하는 위치에 로이신을 포함하는 동몰량의 bGH 보다 젖소의 유즙생산을 향상시킬 수 있는 본질적으로 순수한 발린 bGH를 포함하는 조성물.
  9. 제 8 항에 있어서, 본질적으로 순수한 bGH는 bGH(A,V)와 met-bGH(V)로 구성된 군으로 부터 선택된 것임을 특징으로 하는 조성물.
  10. 제조합 DNA 기술에 의하여 미생물내에서 생성된 발린 bGH를 포함함을 특징으로 하는 조성물.
  11. 제 1 항. 제 4 항 또는 제 5 항 중의 어느 한 항의 조성물을 유즙분비를 촉진시킬 수 있는 양으로 젖소에 투여함을 특징으로 하는 젖소의 유즙분비를 향상시키는 방법.
  12. 혼주된 뇌하수에 bGH를 동몰량으로 투여한 경우보다 유즙분비를 향상시킬 수 있는 제 1 항, 제 2 항, 제 6 항 또는 제10항 중의 어느 한 항의 조성물을 유즙분비촉진량으로 젖소에 투여함을 특징으로 하는 젖소의 유즙분비를 향상시키는 방법.
  13. 발린을 포함하는 위치에 로이신을 포함하는 bGH를 동몰량으로 투여한 경우보다 유즙분비를 향상시킬 수 있는 제1,6 또는 제10항 중 어느 한 항의 조성합을 유즙분비 촉진량으로 젖소에 투여함을 특징으로 하는 젖소의 유즙분비를 향상시키는 방법.
  14. 본질적으로 순수한 발린 bGH를 유즙분비촉진량으로 포함하는 조성물을 투여함을 특징으로 하는 젖소의 유즙생산을 향상시키는 방법.
  15. 제 14 항에 있어서, 발린 bGH는 bGH(A,V)를 포함함을 특징으로 하는 방법.
  16. 번역출발신호인 메티오인 코돈을 트함하는 1개 내지 약 3개의 인접하는 메티오닌코돈을 바로 뒤에 N-말단 알라닌을 갖는 이형의 폴리펩타이드에 대한 코돈들을 포함하는 게놈의 DNA를 선택된 세균내에서 발현시키고, 세균내에서 생산된 N-말단 알라닌을 갖는 폴리펩타이드를 회수함을 특징으로 하는 세균에 의한 N-말단 알라닌을 갖는 이형의 폴리펩타이드의 생산 방법.
  17. 제16항에 있어서, DNA발현에 의하여 세균들내에서 생산된 폴리펩타이드의 최소한 약 80w/w%가 N-말단 알라닌을 포함함을 특징으로 하는 방법.
  18. 제16항에 있어서, 세균은 대장균임을 특징으로 하는 방법.
  19. 제16항에 있어서, 생산된 폴리펩타이드는 자연적으로 생산되는 진정핵의 폴리펩타이드와 본질적으로 동일한 아미노산 서열을 갖는 것을 특징으로 하는 방법.
  20. 제19항에 있어서, 진정핵의 폴리펩타이드는 소마토트로 핀활성을 갖는 것을 특징으로 하는 방법.
  21. 제19항에 있어서, 생성된 폴리펩타이드는 유즙분비, 촉진활성을 갖는 것을 특징으로 하는 방법.
  22. 제16항의 방법에 의하여 제조된 N-말단알라닌을 갖는 폴리펩타이드.
  23. 소유래의 단백질이 아닌 제19항의 방법으로 제조된 bHG(A,L)과 bGH(A,V)로 부터 선택된 폴리펩타이드를 포함하는 조성물.
  24. 돼지유래의 단백질이 아닌 제19항의 방법으로 제조된 pGH(A)를 포함하는 조성물.
  25. 돼지유래의 단백질이 아닌 pGH(A)를 포함하는 조성물.
  26. 제25항에 있어서, 돼지의 발육전 성장을 촉진시키는데 유용한 조성물.
  27. bGH(A,L), bGH(A,V)와 bGH(A)로 부터 선택된 폴리펩타이드에 대한 코돈을 바로 앞에 번역 출발신호인 메티오닌 코돈을 포함하는 인접 메티오닌 코돈들을 1개 내지 약 3개 포함하는 DNA가 삽입된 세균성 플라스미드와 박테리오 파아지 각각으로부터 선택된 세균내에서 DNA를 직접 발현시킬 수 있는 것을 특징으로 하는 제조합
    DNA 벡터.
  28. 세균내에서 작용하는 프로모터, 리보솜결합부위, 번역출발신호인 메티오닌코돈을 포함하는 1개 내지 약 3개의 메티오닌코돈들과 바로 인접한 N-말단에 알라닌을 갖는 이형의 폴리펩타이드에 대하여 암호화된 서열 및 번역종료신호를 차례로 포함하는 유전인자.
  29. 실질적으로 소유래 단백질이 아닌 bGH(A,V)를 유즙분비촉진양 투여하는 것을 특징으로 하는 젖소의 유즙분비를 향상시키는 방법.
    ※ 참고사항 : 최초출원 내용에 의하여 공개하는 것임.
KR1019860001221A 1985-02-22 1986-02-21 생물학적으로 활성인 단백질의 제조방법 Expired KR920000849B1 (ko)

Applications Claiming Priority (6)

Application Number Priority Date Filing Date Title
US704362 1985-02-22
US704,362 1985-02-22
US06/704,362 US4861868A (en) 1985-02-22 1985-02-22 Production of proteins in procaryotes
US824202 1986-02-04
US06/824,202 US5037806A (en) 1985-02-22 1986-02-04 Biologically active method using somatotropins
US824,202 1986-02-04

Publications (2)

Publication Number Publication Date
KR870008028A true KR870008028A (ko) 1987-09-23
KR920000849B1 KR920000849B1 (ko) 1992-01-30

Family

ID=27107310

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1019860001221A Expired KR920000849B1 (ko) 1985-02-22 1986-02-21 생물학적으로 활성인 단백질의 제조방법

Country Status (22)

Country Link
US (1) US5037806A (ko)
EP (1) EP0193515B1 (ko)
JP (3) JP2583214B2 (ko)
KR (1) KR920000849B1 (ko)
CN (3) CN1051302A (ko)
AT (1) ATE141327T1 (ko)
AU (2) AU596575B2 (ko)
CA (1) CA1338981C (ko)
DE (1) DE3650553T2 (ko)
DK (1) DK80886A (ko)
ES (1) ES8801851A1 (ko)
GR (1) GR860509B (ko)
HU (1) HU210671B (ko)
IE (1) IE80663B1 (ko)
IL (4) IL112402A (ko)
LT (1) LT3916B (ko)
MX (1) MX9203728A (ko)
NO (1) NO300551B1 (ko)
NZ (1) NZ215260A (ko)
PT (1) PT82070B (ko)
RO (1) RO106956B1 (ko)
RU (2) RU2072393C1 (ko)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6692941B1 (en) 1980-08-26 2004-02-17 The Regents Of The University Of California Bovine growth hormone
US7101981B1 (en) 1980-08-26 2006-09-05 Regents Of The University Of California Bovine growth hormone recombinantly produced in E. coli
US4861868A (en) 1985-02-22 1989-08-29 Monsanto Company Production of proteins in procaryotes
US5141922A (en) * 1985-02-22 1992-08-25 Monsanto Company Biologically active proteins and a method for their use
JPH06104070B2 (ja) * 1985-06-26 1994-12-21 ジ・アップジョン・カンパニ− 形質転換した微生物からのソマトトロピンの精製
AU599922B2 (en) * 1985-09-10 1990-08-02 Natinco Nv Improving carcass quality
IL82017A (en) 1986-03-27 1996-01-19 Monsanto Co Increased production of protein in bacteria by using a ribosomal linker site based on bacteriophage T7 gene 01
GB8701848D0 (en) * 1987-01-28 1987-03-04 Celltech Ltd Polypeptides
US5244882A (en) * 1987-03-12 1993-09-14 Amgen, Inc. Porcine growth hormone analogs, and compositions
US5104806A (en) * 1987-03-12 1992-04-14 Amgen, Inc. Porcine growth hormone analogs encoding dna
US4863736A (en) 1987-03-16 1989-09-05 Monsanto Company Somatotropin prolonged release
WO1989007651A2 (en) * 1988-02-17 1989-08-24 The Upjohn Company Methods for controlling norleucine content in polypeptides
US5130422A (en) * 1988-08-29 1992-07-14 Monsanto Company Variant somatotropin-encoding DNA
US5089473A (en) * 1988-08-29 1992-02-18 Monsanto Company Somatotropin variants and their use
KR927003633A (ko) * 1989-07-10 1992-12-18 로버트 에이. 아미테이지 소마토트로핀 유사체
US5663305A (en) * 1989-07-10 1997-09-02 The Upjohn Company Somatotropin analogs
DE3930522A1 (de) * 1989-09-13 1991-03-21 Bayer Ag Rekombinante aprotinin-varianten - gentechnisches verfahren zur mikrobiellen herstellung von homogen prozessierten aprotinin-varianten sowie die therapeutische anwendung derselben
US6583115B1 (en) 1989-10-12 2003-06-24 Ohio University/Edison Biotechnology Institute Methods for treating acromegaly and giantism with growth hormone antagonists
US6787336B1 (en) 1989-10-12 2004-09-07 Ohio University/Edison Biotechnology Institute DNA encoding growth hormone antagonists
US5350836A (en) * 1989-10-12 1994-09-27 Ohio University Growth hormone antagonists
US5958879A (en) * 1989-10-12 1999-09-28 Ohio University/Edison Biotechnology Institute Growth hormone receptor antagonists and methods of reducing growth hormone activity in a mammal
US5951972A (en) * 1990-05-04 1999-09-14 American Cyanamid Company Stabilization of somatotropins and other proteins by modification of cysteine residues
US5767080A (en) * 1996-05-01 1998-06-16 Cargill, Incorporated Enhanced milk production in dairy cattle
GB9803424D0 (en) * 1998-02-18 1998-04-15 Pfizer Ltd Performance enhancement
EP1120425B1 (en) 1998-10-05 2009-08-26 Takeda Pharmaceutical Company Limited Process for eliminating n-terminal methionine
US6890731B1 (en) * 2000-03-27 2005-05-10 Applera Corporation Isolated human G-protein coupled receptors that are members of the aminergic subfamily, nucleic acid molecules encoding human GPCR proteins, and uses thereof
CN101665788B (zh) * 2009-09-21 2011-11-09 山西大学 人工合成猪生长激素基因及其表达纯化方法
CN101907626A (zh) * 2010-07-20 2010-12-08 广东省农业科学院兽医研究所 一种猪饲料中猪源蛋白的检测方法

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4443539A (en) * 1980-02-05 1984-04-17 The Upjohn Company Process for preparing bovine growth hormone
IL59690A (en) 1980-03-24 1983-11-30 Yeda Res & Dev Production of bovine growth hormone by microorganisms and modified microorganisms adapted to produce it
IE52755B1 (en) * 1980-08-26 1988-02-17 Univ California Bovine pre-growth and growth hormone
JPS58996A (ja) * 1981-06-01 1983-01-06 ザ・ボ−ド・オブ・トラステイ−ズ・ミシガンステ−トユニバ−シテイ− 細菌中での牛成長ホルモン遺伝子のクロ−ン化
US4436824A (en) * 1981-06-09 1984-03-13 Ortho Diagnostic Systems, Inc. Leukocyte migration through antigen containing agaroses for immunocompetence testing
EP0085036A1 (en) * 1982-01-18 1983-08-03 Monsanto Company Method for improved bovine milk production
DE3380262D1 (en) 1982-05-25 1989-08-31 Lilly Co Eli Cloning vectors for expression of exogenous protein
CA1224432A (en) * 1982-08-17 1987-07-21 Gary N. Buell Dna sequences, recombinant dna molecules and processes for producing bovine growth hormone-like polypeptides in high yield
AU2092983A (en) * 1982-11-08 1984-05-17 Genentech Inc. Porcine growth hormone produced by recombinant dna technology
EP0111814A3 (en) * 1982-12-16 1985-08-14 Mgi Pharma, Inc. The cloning and expression of nucleotide sequences encoding bovine growth hormone
US4661454A (en) * 1983-02-28 1987-04-28 Collaborative Research, Inc. GAL1 yeast promoter linked to non galactokinase gene
CA1340597C (en) * 1984-08-27 1999-06-22 Haim Aviv Expression vectors containing pl promoter, and engineered restriction site for convenient replacement of ribosomal binding site, plasmids containing the vectors, hosts containing the plasmids and related methods
HU196714B (en) * 1984-10-04 1989-01-30 Monsanto Co Process for producing non-aqueous composition comprising somatotropin
US4861868A (en) * 1985-02-22 1989-08-29 Monsanto Company Production of proteins in procaryotes

Also Published As

Publication number Publication date
PT82070B (pt) 1988-01-22
JP2634390B2 (ja) 1997-07-23
JPS61233629A (ja) 1986-10-17
AU4282589A (en) 1990-02-08
HUT40701A (en) 1987-01-28
IL112402A0 (en) 1995-03-30
JP2583214B2 (ja) 1997-02-19
IE80663B1 (en) 1998-11-18
LT3916B (en) 1996-04-25
IL77950A (en) 1996-09-12
DK80886A (da) 1986-11-21
EP0193515B1 (en) 1996-08-14
CN1100272A (zh) 1995-03-22
AU5385486A (en) 1986-08-28
KR920000849B1 (ko) 1992-01-30
IL112403A0 (en) 1995-03-30
JPH07309890A (ja) 1995-11-28
IL112403A (en) 2001-10-31
RO106956B1 (ro) 1993-08-30
RU2094439C1 (ru) 1997-10-27
CA1338981C (en) 1997-03-11
HU210671B (en) 1995-06-28
NO300551B1 (no) 1997-06-16
JPH07304687A (ja) 1995-11-21
CN86101830A (zh) 1986-09-03
ES552234A0 (es) 1988-02-16
US5037806A (en) 1991-08-06
DE3650553T2 (de) 1997-02-27
IE860467L (en) 1986-08-22
ATE141327T1 (de) 1996-08-15
EP0193515A2 (en) 1986-09-03
ES8801851A1 (es) 1988-02-16
CN1051302A (zh) 1991-05-15
MX9203728A (es) 1992-09-01
RU2072393C1 (ru) 1997-01-27
IL112402A (en) 1997-02-18
LTIP1819A (en) 1995-08-25
AU632293B2 (en) 1992-12-24
JP2863113B2 (ja) 1999-03-03
EP0193515A3 (en) 1990-05-30
NO860658L (no) 1986-08-25
PT82070A (en) 1986-03-01
GR860509B (en) 1986-06-18
DK80886D0 (da) 1986-02-21
CN1021973C (zh) 1993-09-01
NZ215260A (en) 1989-01-06
DE3650553D1 (de) 1996-09-19
AU596575B2 (en) 1990-05-10

Similar Documents

Publication Publication Date Title
KR870008028A (ko) 생물학적으로 활성인단백질의 제조방법
US4871835A (en) Analogs of hGH having antagonistic activity, and uses thereof
US4755465A (en) Secretion of correctly processed human growth hormone in E. coli and Pseudomonas
US4859600A (en) Recombinant procaryotic cell containing correctly processed human growth hormone
CA2033176C (en) Growth hormone fusion proteins
US4861868A (en) Production of proteins in procaryotes
CA1340122C (en) Modifications of somatotropins for enhanced stability
KR20000004951A (ko) Scf 유사체및그제조방법_
Le et al. Purification of secreted recombinant proteins from Escherichia coli
EP0257873A2 (en) Method for purifying and isolating two ionic forms of somatomedin c
US6054291A (en) Expression vectors for enhanced production of polypeptides, plasmids containing the vectors, hosts containing the plasmids, products manufactured thereby and related methods
US5527691A (en) Expression vectors containing lambdapl promoter and T1 T2 rRNA termination sequence, plasmids containing the vectors, hosts containing the plasmids and related methods
US5198361A (en) Plasmids for production of met-asp-gln bovine growth hormone, hosts containing the plasmids, products manufactured thereby and related methods
US5112744A (en) Plasmids for the production of human Cu-Zn superoxide dismutase, bacterial hosts containing the plasmids and methods for production and recovery of such superoxide dismutase
US5268284A (en) Ribosome binding site
EP0443790A1 (en) Growth hormone-like glycoproteins
EP0508672A2 (en) Fish prolactin
US5081020A (en) Expression vectors containing λPL promoter, T1 T2 rRNA termination sequence and origin of replication derived from a constitutive high copy number plasmid hosts and related methods
Braun et al. Penicillin-like action of a bactericidal protein(colicin M) of Escherichia coli.
SI8111622B (sl) Interferoni in postopek za njihovo pridobivanje

Legal Events

Date Code Title Description
A201 Request for examination
PA0109 Patent application

St.27 status event code: A-0-1-A10-A12-nap-PA0109

PA0201 Request for examination

St.27 status event code: A-1-2-D10-D11-exm-PA0201

R17-X000 Change to representative recorded

St.27 status event code: A-3-3-R10-R17-oth-X000

PG1501 Laying open of application

St.27 status event code: A-1-1-Q10-Q12-nap-PG1501

E601 Decision to refuse application
E902 Notification of reason for refusal
PE0601 Decision on rejection of patent

St.27 status event code: N-2-6-B10-B15-exm-PE0601

PE0902 Notice of grounds for rejection

St.27 status event code: A-1-2-D10-D21-exm-PE0902

T11-X000 Administrative time limit extension requested

St.27 status event code: U-3-3-T10-T11-oth-X000

T11-X000 Administrative time limit extension requested

St.27 status event code: U-3-3-T10-T11-oth-X000

T11-X000 Administrative time limit extension requested

St.27 status event code: U-3-3-T10-T11-oth-X000

T11-X000 Administrative time limit extension requested

St.27 status event code: U-3-3-T10-T11-oth-X000

T11-X000 Administrative time limit extension requested

St.27 status event code: U-3-3-T10-T11-oth-X000

P11-X000 Amendment of application requested

St.27 status event code: A-2-2-P10-P11-nap-X000

P13-X000 Application amended

St.27 status event code: A-2-2-P10-P13-nap-X000

J2X1 Appeal (before the patent court)

Free format text: APPEAL AGAINST DECISION TO DECLINE REFUSAL

E902 Notification of reason for refusal
PE0902 Notice of grounds for rejection

St.27 status event code: A-1-2-D10-D21-exm-PE0902

P11-X000 Amendment of application requested

St.27 status event code: A-2-2-P10-P11-nap-X000

P13-X000 Application amended

St.27 status event code: A-2-2-P10-P13-nap-X000

G160 Decision to publish patent application
PG1605 Publication of application before grant of patent

St.27 status event code: A-2-2-Q10-Q13-nap-PG1605

E701 Decision to grant or registration of patent right
PE0701 Decision of registration

St.27 status event code: A-1-2-D10-D22-exm-PE0701

GRNT Written decision to grant
PR0701 Registration of establishment

St.27 status event code: A-2-4-F10-F11-exm-PR0701

PR1002 Payment of registration fee

St.27 status event code: A-2-2-U10-U11-oth-PR1002

Fee payment year number: 1

PR1001 Payment of annual fee

St.27 status event code: A-4-4-U10-U11-oth-PR1001

Fee payment year number: 4

J204 Request for invalidation trial [patent]
PR1001 Payment of annual fee

St.27 status event code: A-4-4-U10-U11-oth-PR1001

Fee payment year number: 5

PR1001 Payment of annual fee

St.27 status event code: A-4-4-U10-U11-oth-PR1001

Fee payment year number: 6

J2X1 Appeal (before the patent court)

Free format text: INVALIDATION IN ENTIRETY

PJ2001 Appeal

St.27 status event code: A-5-5-V10-V12-crt-PJ2001

PR1001 Payment of annual fee

St.27 status event code: A-4-4-U10-U11-oth-PR1001

Fee payment year number: 7

J206 Request for trial to confirm the scope of a patent right
PJ0206 Trial to confirm the scope of a patent

St.27 status event code: A-5-5-V10-V11-apl-PJ0206

PR1001 Payment of annual fee

St.27 status event code: A-4-4-U10-U11-oth-PR1001

Fee payment year number: 8

PR1001 Payment of annual fee

St.27 status event code: A-4-4-U10-U11-oth-PR1001

Fee payment year number: 9

J301 Trial decision

Free format text: TRIAL DECISION FOR CONFIRMATION OF THE SCOPE OF RIGHT_DEFENSIVE REQUESTED 19981104

Effective date: 20000429

PJ1301 Trial decision

St.27 status event code: A-5-5-V10-V15-crt-PJ1301

Decision date: 20000429

Appeal event data comment text: Appeal Kind Category : Confirmation of the scope of right_defensive, Appeal Ground Text : 51483

Appeal request date: 19981104

Appellate body name: Patent Examination Board

Decision authority category: Office appeal board

Decision identifier: 1998100001478

Decision text: 51483 . .

J2X1 Appeal (before the patent court)

Free format text: CONFIRMATION OF THE SCOPE OF RIGHT_DEFENSIVE

PJ2001 Appeal

St.27 status event code: A-5-5-V10-V12-crt-PJ2001

R18-X000 Changes to party contact information recorded

St.27 status event code: A-5-5-R10-R18-oth-X000

R18-X000 Changes to party contact information recorded

St.27 status event code: A-5-5-R10-R18-oth-X000

PR1001 Payment of annual fee

St.27 status event code: A-4-4-U10-U11-oth-PR1001

Fee payment year number: 10

J2X2 Appeal (before the supreme court)

Free format text: APPEAL BEFORE THE SUPREME COURT FOR CONFIRMATION OF THE SCOPE OF RIGHT_DEFENSIVE

PJ2002 Appeal before the supreme court

St.27 status event code: A-5-5-V10-V12-crt-PJ2002

PR1001 Payment of annual fee

St.27 status event code: A-4-4-U10-U11-oth-PR1001

Fee payment year number: 11

J2X2 Appeal (before the supreme court)

Free format text: APPEAL BEFORE THE SUPREME COURT FOR INVALIDATION IN ENTIRETY

PJ2002 Appeal before the supreme court

St.27 status event code: A-5-5-V10-V12-crt-PJ2002

PN2301 Change of applicant

St.27 status event code: A-5-5-R10-R13-asn-PN2301

St.27 status event code: A-5-5-R10-R11-asn-PN2301

PR1001 Payment of annual fee

St.27 status event code: A-4-4-U10-U11-oth-PR1001

Fee payment year number: 12

R18-X000 Changes to party contact information recorded

St.27 status event code: A-5-5-R10-R18-oth-X000

PR1001 Payment of annual fee

St.27 status event code: A-4-4-U10-U11-oth-PR1001

Fee payment year number: 13

R18-X000 Changes to party contact information recorded

St.27 status event code: A-5-5-R10-R18-oth-X000

J302 Written judgement (patent court)

Free format text: JUDGMENT (PATENT COURT) FOR INVALIDATION IN ENTIRETY REQUESTED 19970425

Effective date: 20011221

J303 Written judgement (supreme court)

Free format text: JUDGMENT (SUPREME COURT) FOR INVALIDATION IN ENTIRETY REQUESTED 20020201

Effective date: 20040611

PJ1302 Judgment (patent court)

St.27 status event code: A-5-5-V10-V15-crt-PJ1302

Decision date: 20011221

Decision identifier: 1998200000645

Decision authority category: National patent court

Appeal event data comment text: Appeal Kind Category : Invalidation in entirety, Appeal Ground Text : 1995 936 (51483)

Appeal request date: 19970425

Appellate body name: Patent Court

Decision text: 1997. 3. 31. 95936 .

PJ1303 Judgment (supreme court)

St.27 status event code: A-5-5-V10-V15-crt-PJ1303

Decision date: 20040611

Decision authority category: Court of appeal

Appeal event data comment text: Appeal Kind Category : Invalidation in entirety, Appeal Ground Text : 1998 645 (0051483)

Appeal request date: 20020201

Appellate body name: Supreme Court

Decision identifier: 2002300000260

PJ2201 Remand (intellectual property tribunal)

St.27 status event code: A-5-5-V10-V14-crt-PJ2201

Appeal event data comment text: Appeal Kind Category : Invalidation in entirety, Appeal Ground Text : 1998 645 (51483)

Appellate body name: Patent Examination Board

Appeal request date: 20040623

Decision identifier: 2004130000052

Decision authority category: Office appeal board

Decision date: 20050228

J302 Written judgement (patent court)

Free format text: JUDGMENT (PATENT COURT) FOR CONFIRMATION OF THE SCOPE OF RIGHT_DEFENSIVE REQUESTED 20000617

Effective date: 20011221

J303 Written judgement (supreme court)

Free format text: JUDGMENT (SUPREME COURT) FOR CONFIRMATION OF THE SCOPE OF RIGHT_DEFENSIVE REQUESTED 20020117

Effective date: 20040611

PJ1302 Judgment (patent court)

St.27 status event code: A-5-5-V10-V15-crt-PJ1302

Decision date: 20011221

Decision identifier: 2000200003852

Decision authority category: National patent court

Appeal event data comment text: Appeal Kind Category : Confirmation of the scope of right_defensive, Appeal Ground Text : 1998 1478 (0051483 )

Appeal request date: 20000617

Appellate body name: Patent Court

PJ1303 Judgment (supreme court)

St.27 status event code: A-5-5-V10-V15-crt-PJ1303

Decision date: 20040611

Decision authority category: Court of appeal

Appeal event data comment text: Appeal Kind Category : Confirmation of the scope of right_defensive, Appeal Ground Text : 2000 3852 (0051483 )

Appeal request date: 20020117

Appellate body name: Supreme Court

Decision identifier: 2002300000253

LAPS Lapse due to unpaid annual fee
PC1903 Unpaid annual fee

St.27 status event code: A-4-4-U10-U13-oth-PC1903

Not in force date: 20050131

Payment event data comment text: Termination Category : DEFAULT_OF_REGISTRATION_FEE

J301 Trial decision

Free format text: TRIAL DECISION FOR INVALIDATION IN ENTIRETY REQUESTED 20040623

Effective date: 20050228

PJ1301 Trial decision

St.27 status event code: A-5-5-V10-V15-crt-PJ1301

Decision date: 20050228

Appeal event data comment text: Appeal Kind Category : Invalidation in entirety, Appeal Ground Text : 1998 645 (51483)

Appeal request date: 20040623

Appellate body name: Patent Examination Board

Decision authority category: Office appeal board

Decision identifier: 2004130000052

R18-X000 Changes to party contact information recorded

St.27 status event code: A-5-5-R10-R18-oth-X000

PC1903 Unpaid annual fee

St.27 status event code: N-4-6-H10-H13-oth-PC1903

Ip right cessation event data comment text: Termination Category : DEFAULT_OF_REGISTRATION_FEE

Not in force date: 20050131

R18-X000 Changes to party contact information recorded

St.27 status event code: A-5-5-R10-R18-oth-X000

R18-X000 Changes to party contact information recorded

St.27 status event code: A-5-5-R10-R18-oth-X000